Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 53 entries
Sorted by: Best Match Show Resources per page
Neuroanatomical circuits in depression: implications for treatment mechanisms.

Psychopharmacology bulletin

Drevets WC, Raichle ME.
PMID: 1480730
Psychopharmacol Bull. 1992;28(3):261-74.

We previously investigated the functional neuroanatomy of familial pure depressive disease (FPDD) using positron emission tomography (PET) measurements of regional blood flow and obtained evidence that flow is increased in the left prefrontal cortex, amygdala, and medial thalamus and...

Cite
Drevets WC, Raichle ME. Neuroanatomical circuits in depression: implications for treatment mechanisms. Psychopharmacol Bull. 1992;28(3):261-74
Drevets, W. C., & Raichle, M. E. (1992). Neuroanatomical circuits in depression: implications for treatment mechanisms. Psychopharmacology bulletin, 28(3), 261-74.
Drevets, W C, and Raichle, M E. "Neuroanatomical circuits in depression: implications for treatment mechanisms." Psychopharmacology bulletin vol. 28,3 (1992): 261-74.
Drevets WC, Raichle ME. Neuroanatomical circuits in depression: implications for treatment mechanisms. Psychopharmacol Bull. 1992;28(3):261-74. PMID: 1480730.
Copy Download .nbib Format: NLM
Prosthetic valve endocarditis caused by Candida lusitaniae, an uncommon pathogen: a case report.

Journal of medical case reports

Michel RG, Kinasewitz GT, Drevets DA, Levin JH, Warden DW.
PMID: 19830215
J Med Case Rep. 2009 May 14;3:7611. doi: 10.1186/1752-1947-3-7611.

INTRODUCTION: Candida lusitaniae was originally described as a human pathogen in 1979 and typically affects immunocompromised patients.CASE PRESENTATION: We describe a case of prosthetic valve endocarditis with Candida lusitaniae in an immunocompetent 62-year-old woman following aortic valve replacement. In...

Cite
Michel RG, Kinasewitz GT, Drevets DA, et al. Prosthetic valve endocarditis caused by Candida lusitaniae, an uncommon pathogen: a case report. J Med Case Rep. 2009;3:7611doi: 10.1186/1752-1947-3-7611.
Michel, R. G., Kinasewitz, G. T., Drevets, D. A., Levin, J. H., & Warden, D. W. (2009). Prosthetic valve endocarditis caused by Candida lusitaniae, an uncommon pathogen: a case report. Journal of medical case reports, 37611. https://doi.org/10.1186/1752-1947-3-7611
Michel, Ross G, et al. "Prosthetic valve endocarditis caused by Candida lusitaniae, an uncommon pathogen: a case report." Journal of medical case reports vol. 3 (2009): 7611. doi: https://doi.org/10.1186/1752-1947-3-7611
Michel RG, Kinasewitz GT, Drevets DA, Levin JH, Warden DW. Prosthetic valve endocarditis caused by Candida lusitaniae, an uncommon pathogen: a case report. J Med Case Rep. 2009 May 14;3:7611. doi: 10.1186/1752-1947-3-7611. PMID: 19830215; PMCID: PMC2726537.
Copy Download .nbib Format: NLM
Catecholamine depletion in first-degree relatives of individuals with mood disorders: An [(18)F]fluorodeoxyglucose positron emission tomography study.

NeuroImage. Clinical

Savitz J, Nugent AC, Bellgowan PS, Wright N, Tinsley R, Zarate CA, Herscovitch P, Drevets WC.
PMID: 24179788
Neuroimage Clin. 2013 Mar 05;2:341-55. doi: 10.1016/j.nicl.2013.02.004. eCollection 2013.

Catecholamine depletion with alpha-methylparatyrosine (AMPT) has previously been shown to induce depressive symptoms in currently remitted patients with major depressive disorder (MDD) but not healthy controls. Thus sensitivity to catecholamine depletion has been hypothesized to be an endophenotype of...

Cite
Savitz J, Nugent AC, Bellgowan PS, et al. Catecholamine depletion in first-degree relatives of individuals with mood disorders: An [(18)F]fluorodeoxyglucose positron emission tomography study. Neuroimage Clin. 2013;2:341-55doi: 10.1016/j.nicl.2013.02.004.
Savitz, J., Nugent, A. C., Bellgowan, P. S., Wright, N., Tinsley, R., Zarate, C. A., Herscovitch, P., & Drevets, W. C. (2013). Catecholamine depletion in first-degree relatives of individuals with mood disorders: An [(18)F]fluorodeoxyglucose positron emission tomography study. NeuroImage. Clinical, 2341-55. https://doi.org/10.1016/j.nicl.2013.02.004
Savitz, Jonathan, et al. "Catecholamine depletion in first-degree relatives of individuals with mood disorders: An [(18)F]fluorodeoxyglucose positron emission tomography study." NeuroImage. Clinical vol. 2 (2013): 341-55. doi: https://doi.org/10.1016/j.nicl.2013.02.004
Savitz J, Nugent AC, Bellgowan PS, Wright N, Tinsley R, Zarate CA, Herscovitch P, Drevets WC. Catecholamine depletion in first-degree relatives of individuals with mood disorders: An [(18)F]fluorodeoxyglucose positron emission tomography study. Neuroimage Clin. 2013 Mar 05;2:341-55. doi: 10.1016/j.nicl.2013.02.004. eCollection 2013. PMID: 24179788; PMCID: PMC3778263.
Copy Download .nbib Format: NLM
Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study.

Focus (American Psychiatric Publishing)

Canuso CM, Singh JB, Fedgchin M, Alphs L, Lane R, Lim P, Pinter C, Hough D, Sanacora G, Manji H, Drevets WC.
PMID: 32015715
Focus (Am Psychiatr Publ). 2019 Jan;17(1):55-65. doi: 10.1176/appi.focus.17105. Epub 2019 Jan 07.

(Reprinted with permission from

Cite
Canuso CM, Singh JB, Fedgchin M, et al. Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study. Focus (Am Psychiatr Publ). 2019;17(1):55-65doi: 10.1176/appi.focus.17105.
Canuso, C. M., Singh, J. B., Fedgchin, M., Alphs, L., Lane, R., Lim, P., Pinter, C., Hough, D., Sanacora, G., Manji, H., & Drevets, W. C. (2019). Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study. Focus (American Psychiatric Publishing), 17(1), 55-65. https://doi.org/10.1176/appi.focus.17105
Canuso, Carla M, et al. "Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study." Focus (American Psychiatric Publishing) vol. 17,1 (2019): 55-65. doi: https://doi.org/10.1176/appi.focus.17105
Canuso CM, Singh JB, Fedgchin M, Alphs L, Lane R, Lim P, Pinter C, Hough D, Sanacora G, Manji H, Drevets WC. Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study. Focus (Am Psychiatr Publ). 2019 Jan;17(1):55-65. doi: 10.1176/appi.focus.17105. Epub 2019 Jan 07. PMID: 32015715; PMCID: PMC6996073.
Copy Download .nbib Format: NLM
Third Renal Transplant in a Patient With Prune Belly Syndrome.

Cureus

Drevets P, Alslaim H, Saeed I.
PMID: 34993026
Cureus. 2021 Nov 30;13(11):e20048. doi: 10.7759/cureus.20048. eCollection 2021 Nov.

Kidneys are the most frequently transplanted organ in the United States. An infrequently encountered cause of end-stage renal disease requiring permanent dialysis is prune belly syndrome. Prune belly syndrome is mostly seen in males and over a third of...

Cite
Drevets P, Alslaim H, Saeed I. Third Renal Transplant in a Patient With Prune Belly Syndrome. Cureus. 2021;13(11):e20048doi: 10.7759/cureus.20048.
Drevets, P., Alslaim, H., & Saeed, I. (2021). Third Renal Transplant in a Patient With Prune Belly Syndrome. Cureus, 13(11), e20048. https://doi.org/10.7759/cureus.20048
Drevets, Peter, et al. "Third Renal Transplant in a Patient With Prune Belly Syndrome." Cureus vol. 13,11 (2021): e20048. doi: https://doi.org/10.7759/cureus.20048
Drevets P, Alslaim H, Saeed I. Third Renal Transplant in a Patient With Prune Belly Syndrome. Cureus. 2021 Nov 30;13(11):e20048. doi: 10.7759/cureus.20048. eCollection 2021 Nov. PMID: 34993026; PMCID: PMC8720038.
Copy Download .nbib Format: NLM
Commentary: Do surgeons believe treating atrial fibrillation improves survival yet?.

Seminars in thoracic and cardiovascular surgery

Drevets PD, Lee R.
PMID: 34157380
Semin Thorac Cardiovasc Surg. 2021 Jun 23; doi: 10.1053/j.semtcvs.2021.06.014. Epub 2021 Jun 23.

No abstract available.

Cite
Drevets PD, Lee R. Commentary: Do surgeons believe treating atrial fibrillation improves survival yet?. Semin Thorac Cardiovasc Surg. 2021;doi: 10.1053/j.semtcvs.2021.06.014.
Drevets, P. D., & Lee, R. (2021). Commentary: Do surgeons believe treating atrial fibrillation improves survival yet?. Seminars in thoracic and cardiovascular surgery, . https://doi.org/10.1053/j.semtcvs.2021.06.014
Drevets, Peter D, and Lee, Richard. "Commentary: Do surgeons believe treating atrial fibrillation improves survival yet?." Seminars in thoracic and cardiovascular surgery vol. (2021). doi: https://doi.org/10.1053/j.semtcvs.2021.06.014
Drevets PD, Lee R. Commentary: Do surgeons believe treating atrial fibrillation improves survival yet?. Semin Thorac Cardiovasc Surg. 2021 Jun 23; doi: 10.1053/j.semtcvs.2021.06.014. Epub 2021 Jun 23. PMID: 34157380.
Copy Download .nbib Format: NLM
Corrigendum to "Anionic phospholipid expression as a molecular target in Listeria monocytogenes and Escherichia coli" [International Journal of Antimicrobial Agents, Volume 56, Issue 6, December 2020, 106183].

International journal of antimicrobial agents

McKernan P, Cassidy B, Woodward A, Battiste J, Drevets D, Harrison R.
PMID: 34518079
Int J Antimicrob Agents. 2021 Nov;58(5):106423. doi: 10.1016/j.ijantimicag.2021.106423. Epub 2021 Sep 10.

No abstract available.

Cite
McKernan P, Cassidy B, Woodward A, et al. Corrigendum to "Anionic phospholipid expression as a molecular target in Listeria monocytogenes and Escherichia coli" [International Journal of Antimicrobial Agents, Volume 56, Issue 6, December 2020, 106183]. Int J Antimicrob Agents. 2021;58(5):106423doi: 10.1016/j.ijantimicag.2021.106423.
McKernan, P., Cassidy, B., Woodward, A., Battiste, J., Drevets, D., & Harrison, R. (2021). Corrigendum to "Anionic phospholipid expression as a molecular target in Listeria monocytogenes and Escherichia coli" [International Journal of Antimicrobial Agents, Volume 56, Issue 6, December 2020, 106183]. International journal of antimicrobial agents, 58(5), 106423. https://doi.org/10.1016/j.ijantimicag.2021.106423
McKernan, Patrick, et al. "Corrigendum to "Anionic phospholipid expression as a molecular target in Listeria monocytogenes and Escherichia coli" [International Journal of Antimicrobial Agents, Volume 56, Issue 6, December 2020, 106183]." International journal of antimicrobial agents vol. 58,5 (2021): 106423. doi: https://doi.org/10.1016/j.ijantimicag.2021.106423
McKernan P, Cassidy B, Woodward A, Battiste J, Drevets D, Harrison R. Corrigendum to "Anionic phospholipid expression as a molecular target in Listeria monocytogenes and Escherichia coli" [International Journal of Antimicrobial Agents, Volume 56, Issue 6, December 2020, 106183]. Int J Antimicrob Agents. 2021 Nov;58(5):106423. doi: 10.1016/j.ijantimicag.2021.106423. Epub 2021 Sep 10. PMID: 34518079.
Copy Download .nbib Format: NLM
Bordetella bronchiseptica infections in patients with HIV/AIDS: A case report and review of the literature.

Medicine

Gujju VR, Akram B, Shibib DR, McGhee MA, Drevets DA.
PMID: 34941094
Medicine (Baltimore). 2021 Dec 23;100(51):e28244. doi: 10.1097/MD.0000000000028244.

RATIONALE: Bordetella bronchiseptica is a common cause of upper respiratory tract infections in domesticated dogs and cats and a rare zoonotic pathogen in immunocompromised humans. With increasing numbers of people acquiring pets and spending time with them in confined...

Cite
Gujju VR, Akram B, Shibib DR, et al. Bordetella bronchiseptica infections in patients with HIV/AIDS: A case report and review of the literature. Medicine (Baltimore). 2021;100(51):e28244doi: 10.1097/MD.0000000000028244.
Gujju, V. R., Akram, B., Shibib, D. R., McGhee, M. A., & Drevets, D. A. (2021). Bordetella bronchiseptica infections in patients with HIV/AIDS: A case report and review of the literature. Medicine, 100(51), e28244. https://doi.org/10.1097/MD.0000000000028244
Gujju, Veena R, et al. "Bordetella bronchiseptica infections in patients with HIV/AIDS: A case report and review of the literature." Medicine vol. 100,51 (2021): e28244. doi: https://doi.org/10.1097/MD.0000000000028244
Gujju VR, Akram B, Shibib DR, McGhee MA, Drevets DA. Bordetella bronchiseptica infections in patients with HIV/AIDS: A case report and review of the literature. Medicine (Baltimore). 2021 Dec 23;100(51):e28244. doi: 10.1097/MD.0000000000028244. PMID: 34941094.
Copy Download .nbib Format: NLM
Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder.

Translational psychiatry

Recourt K, de Boer P, Zuiker R, Luthringer R, Kent J, van der Ark P, Van Hove I, van Gerven J, Jacobs G, van Nueten L, Drevets W.
PMID: 31578318
Transl Psychiatry. 2019 Oct 02;9(1):240. doi: 10.1038/s41398-019-0585-4.

In the original Article, Tables two and three had formatting issues which affected their clarity. This has been corrected in the PDF and HTML versions of this Article.

Cite
Recourt K, de Boer P, Zuiker R, et al. Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder. Transl Psychiatry. 2019;9(1):240doi: 10.1038/s41398-019-0585-4.
Recourt, K., de Boer, P., Zuiker, R., Luthringer, R., Kent, J., van der Ark, P., Van Hove, I., van Gerven, J., Jacobs, G., van Nueten, L., & Drevets, W. (2019). Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder. Translational psychiatry, 9(1), 240. https://doi.org/10.1038/s41398-019-0585-4
Recourt, Kasper, et al. "Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder." Translational psychiatry vol. 9,1 (2019): 240. doi: https://doi.org/10.1038/s41398-019-0585-4
Recourt K, de Boer P, Zuiker R, Luthringer R, Kent J, van der Ark P, Van Hove I, van Gerven J, Jacobs G, van Nueten L, Drevets W. Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder. Transl Psychiatry. 2019 Oct 02;9(1):240. doi: 10.1038/s41398-019-0585-4. PMID: 31578318; PMCID: PMC6775147.
Copy Download .nbib Format: NLM
Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II).

The international journal of neuropsychopharmacology

Ionescu DF, Fu DJ, Qiu X, Lane R, Lim P, Kasper S, Hough D, Drevets WC, Manji H, Canuso CM.
PMID: 32861217
Int J Neuropsychopharmacol. 2021 Jan 20;24(1):22-31. doi: 10.1093/ijnp/pyaa068.

BACKGROUND: Patients with major depressive disorder (MDD) having active suicidal ideation with intent require immediate treatment.METHODS: This double-blind study (ASPIRE II) randomized adults (aged 18-64 years) with MDD having active suicidal ideation with intent to esketamine 84 mg or...

Cite
Ionescu DF, Fu DJ, Qiu X, et al. Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II). Int J Neuropsychopharmacol. 2021;24(1):22-31doi: 10.1093/ijnp/pyaa068.
Ionescu, D. F., Fu, D. J., Qiu, X., Lane, R., Lim, P., Kasper, S., Hough, D., Drevets, W. C., Manji, H., & Canuso, C. M. (2021). Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II). The international journal of neuropsychopharmacology, 24(1), 22-31. https://doi.org/10.1093/ijnp/pyaa068
Ionescu, Dawn F, et al. "Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)." The international journal of neuropsychopharmacology vol. 24,1 (2021): 22-31. doi: https://doi.org/10.1093/ijnp/pyaa068
Ionescu DF, Fu DJ, Qiu X, Lane R, Lim P, Kasper S, Hough D, Drevets WC, Manji H, Canuso CM. Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II). Int J Neuropsychopharmacol. 2021 Jan 20;24(1):22-31. doi: 10.1093/ijnp/pyaa068. PMID: 32861217; PMCID: PMC7816667.
Copy Download .nbib Format: NLM
A method-comparison study regarding the validity and reliability of the Lactate Plus analyzer.

BMJ open

Hart S, Drevets K, Alford M, Salacinski A, Hunt BE.
PMID: 23449745
BMJ Open. 2013 Feb 27;3(2). doi: 10.1136/bmjopen-2012-001899. Print 2013.

OBJECTIVES: The aims of this study were to: (1) determine the validity and reliability of the Nova Biomedical Lactate Plus portable analyzer, and quantify any fixed or proportional bias; (2) determine the effect of any bias on the determination...

Cite
Hart S, Drevets K, Alford M, et al. A method-comparison study regarding the validity and reliability of the Lactate Plus analyzer. BMJ Open. 2013;3(2)doi: 10.1136/bmjopen-2012-001899.
Hart, S., Drevets, K., Alford, M., Salacinski, A., & Hunt, B. E. (2013). A method-comparison study regarding the validity and reliability of the Lactate Plus analyzer. BMJ open, 3(2), . https://doi.org/10.1136/bmjopen-2012-001899
Hart, Sarah, et al. "A method-comparison study regarding the validity and reliability of the Lactate Plus analyzer." BMJ open vol. 3,2 (2013). doi: https://doi.org/10.1136/bmjopen-2012-001899
Hart S, Drevets K, Alford M, Salacinski A, Hunt BE. A method-comparison study regarding the validity and reliability of the Lactate Plus analyzer. BMJ Open. 2013 Feb 27;3(2). doi: 10.1136/bmjopen-2012-001899. Print 2013. PMID: 23449745; PMCID: PMC3586176.
Copy Download .nbib Format: NLM
Commentary: Characteristics of traditional pathway applicants may be stable, but for how long?.

The Journal of thoracic and cardiovascular surgery

Drevets PD, Lee R.
PMID: 34602253
J Thorac Cardiovasc Surg. 2021 Sep 20; doi: 10.1016/j.jtcvs.2021.09.025. Epub 2021 Sep 20.

No abstract available.

Cite
Drevets PD, Lee R. Commentary: Characteristics of traditional pathway applicants may be stable, but for how long?. J Thorac Cardiovasc Surg. 2021;doi: 10.1016/j.jtcvs.2021.09.025.
Drevets, P. D., & Lee, R. (2021). Commentary: Characteristics of traditional pathway applicants may be stable, but for how long?. The Journal of thoracic and cardiovascular surgery, . https://doi.org/10.1016/j.jtcvs.2021.09.025
Drevets, Peter D, and Lee, Richard. "Commentary: Characteristics of traditional pathway applicants may be stable, but for how long?." The Journal of thoracic and cardiovascular surgery vol. (2021). doi: https://doi.org/10.1016/j.jtcvs.2021.09.025
Drevets PD, Lee R. Commentary: Characteristics of traditional pathway applicants may be stable, but for how long?. J Thorac Cardiovasc Surg. 2021 Sep 20; doi: 10.1016/j.jtcvs.2021.09.025. Epub 2021 Sep 20. PMID: 34602253.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 53 entries